--- title: Holo-Blister® is a new anti-counterfeiting system for pharmaceutical blister-packs that has just been awarded patents in both the U.S. and Europe description: "Holographyx Inc. has announced that it has recently been granted a U.S. patent for its Holo-Blister®\nproduct along with a European Patent for the development method to apply holograms to the back of blister packs." image: https://news.lifesciencenewswire.com/hubfs/holo-blister%20Uhlmann%20image.png --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (34)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (20)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (15)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (244)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (9)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (36)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (108)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (283)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (35)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Drug Discovery & Development (147)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (55)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (132)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (6)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (25)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (86)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (114)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (4)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (5)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates - ##### SHARE - - - # [Holo-Blister® is a new anti-counterfeiting system for pharmaceutical blister-packs that has just been awarded patents in both the U.S. and Europe](https://news.lifesciencenewswire.com/newsroom/holo-blister-is-a-new-anti-counterfeiting-system-for-pharmaceutical-blister-packs-that-has-just-been-awarded-patents-in-both-the-u.s.-and-europe) February 23, 2022 [![holo-blister Uhlmann image](https://news.lifesciencenewswire.com/hs-fs/hubfs/holo-blister%20Uhlmann%20image.png?width=254&name=holo-blister%20Uhlmann%20image.png)](https://drive.google.com/file/d/1DOGxwJl0NXgbjOD4zLVXMrpqkHtk0JKC/view?usp=sharing)Holographyx Inc. is pleased to announce that it has recently been granted a U.S. patent for its Holo-Blister® product along with a European Patent for the development of this unique and cost-effective method to apply holograms to the back of blister packs using conventional heat-seal blister packaging equipment. Holo-Blister® holograms have been designed so that they will only be visible behind each pill/capsule cavity on the back of each blister pack, thereby allowing the printing of dosage and marketing information on the area surrounding the pill/capsule recess. The size of the worldwide market for counterfeit pharmaceuticals has been estimated to be as much as $200 billion annually. Although anti-counterfeiting measures such as “track and trace” can be used to distinguish legitimate pharmaceutical products from counterfeits, these systems require consumers to go on-line to validate each of their pharmaceutical purchases. Blister-packaging utilizing Holo-Blister® provides consumers with the ability to visually validate the authenticity of their purchases instantly with the use of custom holograms that, prior to the development of Holo-Blister®, would be extremely difficult to manufacture and apply. Holographyx Inc. has been working with the Hazen Paper Company in cooperation with Uhlmann Packaging on the development, testing, and introduction of Holo-Blister®. About Holographyx Inc.: Holographyx Inc was founded in 1993 and developed and marketed the world’s first holographic scratch-off lottery ticket in conjunction with the Hazen Paper Company. Our Holographic scratch-off lottery tickets are now being used on an ongoing basis by a multitude of lotteries including 43 lotteries in the US as well as by more than a dozen additional lotteries worldwide. Holographyx has developed its Holo-Blister® product for the pharmaceutical industry and has been awarded U.S Patent # 11,052,020 B2 & European Patent # EP 3532005 with additional US and worldwide patents pending. Holo-Blister ® is a registered trademark of Holographyx Inc. About Hazen Paper: Hazen Paper was founded in 1925 and is a leading paper converter specializing in holographic origination, film coating, foil and paper lamination, metallizing, gravure printing, specialty coating and rotary embossing to create specialty materials for worldwide use in retail display and POP, luxury, beauty, entertainment and media packaging, bookbinding, scratch-off lottery and other security-related tickets, tags, and cards. Hazen is committed to sustainability, using hydropower produced by the Connecticut River, with certification to supply converted paper and paperboards that are FSC, SFI and PEFC certified. About Uhlmann Packaging: Uhlmann Pac-Systeme GmbH & Co. KG is a global leader in providing systems for packing pharmaceuticals in blister packaging, bottles, and cartons. In addition to its innovative packaging lines, Uhlmann offers consultation, project management, extensive services, and digital solutions from a single source. The company is part of the Uhlmann Group, which achieved a turnover of €423 million in the 2020/21 business year with around 2600 employees. Other companies in the Uhlmann Group are KOCH Pac-Systeme, Cremer Speciaalmachines, Wonder Packing Machinery and Axito. Categories: [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) ##### Browse more news ## Recent releases #### [Enhanced Compliance Inc. (ECI) Appoints Taranjit S. Samra as Head of Medical Device Software Enginee...](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) July 6, 2026 Strengthens ECI’s AI & Digital Transformation capabilities to help clients develop the next generation of software-enabled medical technologies En... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) #### [Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomic...](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) June 16, 2026 New ultra-high-throughput kit enables discovery teams to generate transcriptome-wide compound-response data directly from 1536-well plates Alithea Gen... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) #### [Arscience Biotherapeutics Appoints Gustavo Mahler as Chief Executive Officer](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) June 16, 2026 Seasoned Biopharmaceutical Leader and Board Director Steps Up to Lead the Company’s Next Phase of Growth in Customized Interleukin Therapies ARScience... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)